Delivery Order SPE2DB22D3011-SPE2DB25FQ2ET
Award Date 8/12/25
Potential Completion Date 8/13/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $69,353.78 on September 9, 2025, for the supply of XELJANZ XR 11 mg tablets (30-count units) by the Defense Logistics Agency. This non-set-aside, competitively awarded contract carries a firm fixed price structure and is scheduled for completion by September 10, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $17,873.07 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 8, 2025, for XELJANZ XR 11 mg tablets (30-count packages). The award, which carries an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,437.40 by the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, non-set-aside contract calls for the delivery of XELJANZ XR 11 mg tablets in quantities of 30 units. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for XELJANZ XR 11 mg tablets in 30-count unit doses, valued at $18,565.52 under a firm fixed price contract type. The award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 4, 2025, for Xeljanz 5 mg tablets (60-count units) under a firm fixed price contract with a ceiling value of $19,446.19. This is a non-set-aside competitive award funded by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of September 5, 2025. The place of performance is located in Conshohocken, Pennsylvania, where the vendor maintains its...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,776.31 by the Defense Logistics Agency for XELJANZ XR 11 MG tablets (30-count units) under a firm fixed-price contract type. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and represents a non-set-aside, competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,277.87 on May 30, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30-unit packages. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 2, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction within...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,806.62 by the Defense Logistics Agency (DLA) for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units per package. This is a firm fixed-price, competitively awarded contract with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement requirements through open competition. The contract was awarded on May 28, 2025, with an ultimate completion date of May 29, 2025, and...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 3, 2025, for XELJANZ XR 11 mg tablets in 30-count units, with a ceiling value of $10,286.16. This firm fixed price, non-set-aside contract is scheduled for completion by September 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $64,243.98 to supply XELJANZ XR 11 mg tablets in 30-count units. This non-competitive delivery order, issued on August 13, 2025, represents a firm fixed-price transaction with an ultimate completion date of August 14, 2025. The place of performance is listed as the company's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...